<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/10.15789/1563-0625-IOT-2372</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2372</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Воздействие трансфузий компонентов крови на иммунную систему реципиента</article-title><trans-title-group xml:lang="en"><trans-title>Impact of transfusion of blood components on the recipient immune system</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1022-8127</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глазанова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Glazanova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Валантиновна Глазанова – доктор медицинских наук, руководитель лаборатории иммуногематологии.</p><p>191024, Санкт-Петербург, ул. 2-ая Советская, 16. Тел.: 8 (921) 997-51-31</p></bio><bio xml:lang="en"><p>Glazanova Tatyana V. - PhD, MD (Medicine), Head, Laboratory of Immunohaematology.</p><p>191024, St. Petersburg, 2nd Sovetskaya, 16. Phone: 7 (921) 997-51-31</p></bio><email xlink:type="simple">sherom08@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шилова</surname><given-names>Е. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Shilova</surname><given-names>E. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Романовна Шилова – кандидат медицинских наук, доцент, старший научный сотрудник лаборатории иммуногематологии.</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Senior Research Associate, Laboratory of Immunohaematology.</p><p>St. Petersburg</p></bio><email xlink:type="simple">sherom08@inbox.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чечеткин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chechetkin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александр Викторович Чечеткин – доктор медицинских наук, профессор, заместитель директора.</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Deputy Director, Russian Research Institute of Haematology and Transfusiology.</p><p>St. Petersburg</p></bio><email xlink:type="simple">aschech@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6690-3742</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бубнова</surname><given-names>Л. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Bubnova</surname><given-names>L. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Людмила Николаевна Бубнова – доктор медицинских наук, профессор, заслуженный деятель науки РФ, руководитель Республиканского центра иммунологического типирования тканей РНИИ гематологии и трансфузиологии Федерального медико-биологического агентства; профессор кафедры иммунологии Первый СанктПетербургский ГМУ имени академика И.П. Павлова.</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Honored Researcher of Russia, Head, Russian Center of Tissues Typing, RRIof Haematology and Transfusiology, Federal Medical and Bilogical Agency; Professor, Department of Immunology, First St. Petersburg State I. Pavlov MU.</p><p>St. Petersburg</p></bio><email xlink:type="simple">lnbubnova@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ Российский научно-исследовательский институт гематологии и трансфузиологии Федерального медико-биологического агентства</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Research Institute of Haematology and Transfusiology, Federal Medical and Bilogical Agency</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>.ФГБУ Российский научно-исследовательский институт гематологии и трансфузиологии Федерального медико-биологического агентства</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Research Institute of Haematology and Transfusiology, Federal Medical and Bilogical Agency</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ Российский научно-исследовательский институт гематологии и трансфузиологии Федерального медико-биологического агентства; ФГБУ Российский научно-исследовательский институт гематологии и трансфузиологии Федерального медико-биологического агентства</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Research Institute of Haematology and Transfusiology, Federal Medical and Bilogical Agency; Russian Research Institute of Haematology and Transfusiology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>21</day><month>12</month><year>2021</year></pub-date><volume>23</volume><issue>6</issue><fpage>1307</fpage><lpage>1318</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Глазанова Т.В., Шилова Е.Р., Чечеткин А.В., Бубнова Л.Н., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Глазанова Т.В., Шилова Е.Р., Чечеткин А.В., Бубнова Л.Н.</copyright-holder><copyright-holder xml:lang="en">Glazanova T.V., Shilova E.R., Chechetkin A.V., Bubnova L.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2372">https://www.mimmun.ru/mimmun/article/view/2372</self-uri><abstract><p>Переливания компонентов крови являются неотъемлемой частью лечебных мероприятий при ряде патологических состояний. Однако при проведении гемокомпонентной терапии важно учитывать вероятность посттрансфузионных осложнений, основную часть которых составляют иммунообусловленные побочные явления. Неблагоприятные последствия гемотрансфузий могут проявляться спустя длительный период времени, а патогенез данных явлений может быть ассоциирован не только с наличием аллоантител. Причинами могут быть аллоиммунизация к антигенам HLA, факторы лейкоцитарного происхождения, включая цитокины, продукты дегрануляции лейкоцитов, а также феномен повреждения эритроцитов при хранении (“storage lesion”), иммуномодулирующие свойства внеклеточных везикул или микрочастиц, содержащихся в компонентах крови, и другие факторы. Несмотря на значительное количество публикаций по данной проблеме, остается ряд нерешенных вопросов, связанных с воздействием трансфузий компонентов крови на иммунную систему реципиентов. В обзоре литературы приводятся результаты современных исследований, посвященных изучению данного феномена. Рассматриваются выявленные в последние годы особенности трансфузионно-обусловленной иммуномодуляции (ТОИМ), при переливании различных компонентов крови. Приводятся результаты современных исследований, посвященных изучению данного феномена. Освещена роль плазменных факторов, микрочастиц, тромбоцитов и эритроцитов, HLA-сенсибилизации и микрохимеризма в развитии ТОИМ, приводятся данные об особенностях возникновения ТОИМ в периоперационном периоде. Отдельный раздел обзора содержит сведения о клинических исследованиях, проводившихся за последние годы и посвященных проблеме ТОИМ, в том числе в группах новорожденных, пациентов со злокачественными новообразованиями, у иммунокомпрометированных пациентов после операций на сердце и сосудах. Освещаются данные по частоте наличия феномена ТОИМ у пациентов с ослабленной предыдущим заболеванием или проводимым лечением иммунной системой, наличием выраженной коморбидности, обширным хирургическим торакальным/абдоминальным вмешательством и искусственным кровообращением. На основании проведенных исследований обсуждается роль в снижении частоты развития ТОИМ таких мероприятий при заготовке компонентов крови, как отмывание концентратов эритроцитов, лейкодеплеция, гамма-облучение. Данные опубликованных научных исследований не позволяют окончательно сделать определенные выводы о воздействии трансфузий компонентов крови на иммунную систему реципиентов в связи с различием изучаемых групп больных, особенностей исследуемых нозологий и клинических ситуаций, разноплановостью гемокомпонентов, а также различных стандартов трансфузионной терапии, принятых в разных странах. Тем не менее систематизированный обзор литературы может помочь ориентироваться в вопросах трансфузионно-обусловленной иммуномодуляции.</p></abstract><trans-abstract xml:lang="en"><p>Transfusions of blood provide essential therapeutic measures in a number of pathological conditions. However, when carrying out blood component therapy, it is important to consider probability of post-transfusion complications. Most of them are immune-mediated side effects. The unfavorable consequences of blood transfusions can manifest at long-range time periods, and pathogenesis of these phenomena may be associated not only with the presence of alloantibodies. They may be caused by alloimmunization to HLA antigens, leukocyte factors, including cytokines, products of leukocyte degranulation, as well as storage-related erythrocyte damage («storage lesion»), immunomodulatory properties of extracellular vesicles or microparticles derived from blood components, and other factors. Despite significant number of publications on this issue, a lot of unresolved issues still remain, concerning transfusion-related effects of blood components on the immune system of recipients. The review article provides the results of current studies in this area. We present and discuss the results of current studies and the features of transfusion-mediated immunomodulation (TRIM) revealed over recent years, when transfusing different blood components. The role of plasma factors, microparticles, platelets and erythrocytes, HLA sensitization and microchimerism in the development of TRIM is highlighted, the data on occurrence and clinical features of TRIM in perioperative period are presented. A separate section of the review provides information about recent clinical studies, devoted to the issues of TRIM in different clinical cohorts, including newborns, patients with malignant neoplasms, immunocompromised patients after heart and vascular surgery. The data on TRIM incidence in the patients with exhausted immune system due to previous disease or treatment, severe comorbidity, extensive surgical thoracic/abdominal intervention and artificial circulation are also in scope. As based on the studies performed, the role of distinct measures, e.g., washing of erythrocyte concentrates, leukodepletion, and gamma irradiation are discussed in view of potential TRIM prevention. The results of published research do not allow us to draw definite conclusions about the effects of blood component transfusion on the immune system of recipients with respect to differences between the studied groups of patients, characteristics of the studied disorders and clinical situations, diversity of hemocomponents, as well as varying standards of transfusion therapy adopted in different countries. However, the systematic literature review may provide some guidance in transfusion-mediated immune modulation.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>трансфузии компонентов крови</kwd><kwd>трансфузионно-обусловленная иммуномодуляция</kwd><kwd>аллоиммунизация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>blood components</kwd><kwd>transfusion</kwd><kwd>transfusion-related immunomodulation</kwd><kwd>alloimmunization</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Эйхлер О.В., Чечеткин А.В., Аджигитова Е.В., Данильченко В.В., Минеева Н.В., Солдатенков В.Е., Кробинец И.И. Характеристика осложнений, возникших после переливания донорской крови и ее компонентов, в медицинских организациях Российской Федерации в 2018 году // Трансфузиология, 2019. Т.20, № 4. С. 301-309.</mixed-citation><mixed-citation xml:lang="en">Eikhler O.V., Chechetkin A.V., Adzhigitova E.V., Danilchenko V.V., Mineeva N.V., Soldatenkov V.E., Krobinets I.I. Characteristics of complications occurring after transfusion of donor blood and its components, in medical esteblishments of the Russian Federation in 2018. Transfuziologiya = Transfusiology, 2019, Vol. 20, no. 4, pp. 301-309. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Aatonen M., Gronholm M., Siljander P. Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin. Thromb. Hemost., 2012, Vol. 38, no. 1, pp. 102-113.</mixed-citation><mixed-citation xml:lang="en">Aatonen M., Gronholm M., Siljander P. Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin. Thromb. Hemost., 2012, Vol. 38, no. 1, pp. 102-113.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev., 2006, Vol. 1, CD005033. doi: 10.1002/14651858.CD005033.pub2.</mixed-citation><mixed-citation xml:lang="en">Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev., 2006, Vol. 1, CD005033. doi: 10.1002/14651858.CD005033.pub2.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Almizraq R., Seghatchian J., Acker J. Extracellular vesicles in transfusion-related immunomodulation and the role of blood component manufacturing. Transfus.Apher. Sci., 2016, Vol. 55, no. 3, pp. 281-291.</mixed-citation><mixed-citation xml:lang="en">Almizraq R., Seghatchian J., Acker J. Extracellular vesicles in transfusion-related immunomodulation and the role of blood component manufacturing. Transfus.Apher. Sci., 2016, Vol. 55, no. 3, pp. 281-291.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Almizraq R., Kipkeu B., Acker J. Platelet vesicles are potent inflammatory mediators in red blood cell products and washing reduces the inflammatory phenotype. Transfusion, 2019, Vol. 60, no. 2, pp. 378-390.</mixed-citation><mixed-citation xml:lang="en">Almizraq R., Kipkeu B., Acker J. Platelet vesicles are potent inflammatory mediators in red blood cell products and washing reduces the inflammatory phenotype. Transfusion, 2019, Vol. 60, no. 2, pp. 378-390.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Apelseth T., Hervig T., Wentzel-Larsen T., Petersen K., Reikvam H, Bruserud O. A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia. Eur. Cytokine Netw., 2011, Vol. 22, no. 1, pp. 52-62.</mixed-citation><mixed-citation xml:lang="en">Apelseth T., Hervig T., Wentzel-Larsen T., Petersen K., Reikvam H, Bruserud O. A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia. Eur. Cytokine Netw., 2011, Vol. 22, no. 1, pp. 52-62.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Arraud N., Linares R., Tan S., Gounou C., Pasquet J.-M., Mornet S., Brisson A.R. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J. Thromb. Haemost., 2014, Vol. 12, no. 5, pp. 614-627.</mixed-citation><mixed-citation xml:lang="en">Arraud N., Linares R., Tan S., Gounou C., Pasquet J.-M., Mornet S., Brisson A.R. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J. Thromb. Haemost., 2014, Vol. 12, no. 5, pp. 614-627.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Atzil S., Arad M., Glasner A., Abiri N., Avraham R., Greenfeld K., Rosenne E., Beilin B., Ben-Eliyahu S. Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology, 2008, Vol. 109, no. 6, pp. 989-997.</mixed-citation><mixed-citation xml:lang="en">Atzil S., Arad M., Glasner A., Abiri N., Avraham R., Greenfeld K., Rosenne E., Beilin B., Ben-Eliyahu S. Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology, 2008, Vol. 109, no. 6, pp. 989-997.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Baek J. H., Yalamanoglu A., Gao Y., Guenster R., Spahn D.R., Schaer D.J., Buehler P.W. Iron accelerates hemoglobin oxidation increasing mortality in vascular diseased guinea pigs following transfusion of stored blood. JCI Insight, 2017, Vol. 2, e93577. doi: 10.1172/jci.insight.93577.</mixed-citation><mixed-citation xml:lang="en">Baek J. H., Yalamanoglu A., Gao Y., Guenster R., Spahn D.R., Schaer D.J., Buehler P.W. Iron accelerates hemoglobin oxidation increasing mortality in vascular diseased guinea pigs following transfusion of stored blood. JCI Insight, 2017, Vol. 2, e93577. doi: 10.1172/jci.insight.93577.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Baumgartner J.М., Nydam T.L., Clarke J.H., Banerjee A., Silliman C.C., McCarter M.D. Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells. J. Interferon Cytokine Res., 2009, Vol. 29, no. 6, pp. 333-338.</mixed-citation><mixed-citation xml:lang="en">Baumgartner J.М., Nydam T.L., Clarke J.H., Banerjee A., Silliman C.C., McCarter M.D. Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells. J. Interferon Cytokine Res., 2009, Vol. 29, no. 6, pp. 333-338.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Baumgartner J., Silliman C.C., Moore E.E., Banerjee A., McCarter M. Stored red blood cell transfusion induces regulatory T cells. J. Am. Coll. Surg., 2009, Vol. 208, no. 1, pp. 110-119.</mixed-citation><mixed-citation xml:lang="en">Baumgartner J., Silliman C.C., Moore E.E., Banerjee A., McCarter M. Stored red blood cell transfusion induces regulatory T cells. J. Am. Coll. Surg., 2009, Vol. 208, no. 1, pp. 110-119.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Belizaire R., Prakash P., Richter J., Robinson B.R., Edwards M.J., Caldwell C., Lentsch A., Pritts T.A. Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation. J. Am. Coll. Surg., 2012, Vol. 214, no. 4, pp. 648-655.</mixed-citation><mixed-citation xml:lang="en">Belizaire R., Prakash P., Richter J., Robinson B.R., Edwards M.J., Caldwell C., Lentsch A., Pritts T.A. Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation. J. Am. Coll. Surg., 2012, Vol. 214, no. 4, pp. 648-655.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Blajchman M. Immunomodulation and blood transfusion. Am. J. Ther., 2002, Vol. 9, no. 5, pp. 389-395.</mixed-citation><mixed-citation xml:lang="en">Blajchman M. Immunomodulation and blood transfusion. Am. J. Ther., 2002, Vol. 9, no. 5, pp. 389-395.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bury T., Corhay J., Radermecker M. Histamine-induced inhibition of neutrophil chemotaxis and T-lymphocyte proliferation in man. Allergy, 1992, Vol. 47, no. 6, pp. 624-629.</mixed-citation><mixed-citation xml:lang="en">Bury T., Corhay J., Radermecker M. Histamine-induced inhibition of neutrophil chemotaxis and T-lymphocyte proliferation in man. Allergy, 1992, Vol. 47, no. 6, pp. 624-629.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med., 2003, Vol. 197, no. 4, pp. 403-411.</mixed-citation><mixed-citation xml:lang="en">Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med., 2003, Vol. 197, no. 4, pp. 403-411.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X., Yang J., Hu S., Nie H., Mao G., Chen H. Increased expression of CD86 and reduced production of IL-12 and IL-10 by monocyte-derived dendritic cells from allergic asthmatics and their effects on Th1- and Th2-type cytokine balance. Respiration, 2006, Vol. 73, no. 1, pp. 34-40.</mixed-citation><mixed-citation xml:lang="en">Chen X., Yang J., Hu S., Nie H., Mao G., Chen H. Increased expression of CD86 and reduced production of IL-12 and IL-10 by monocyte-derived dendritic cells from allergic asthmatics and their effects on Th1- and Th2-type cytokine balance. Respiration, 2006, Vol. 73, no. 1, pp. 34-40.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Coutant F., Perrin-Cocon L., Agaugue S., Delair T., André P., Lotteau. V. Mature dendritic cell generation promoted by lysophosphatidylcholine. J. Immunol., 2002, Vol. 169, no. 4, pp. 1688-1695.</mixed-citation><mixed-citation xml:lang="en">Coutant F., Perrin-Cocon L., Agaugue S., Delair T., André P., Lotteau. V. Mature dendritic cell generation promoted by lysophosphatidylcholine. J. Immunol., 2002, Vol. 169, no. 4, pp. 1688-1695.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cross J., Bradbury R., Fulford A., Jallow A., Wegmüller R., Prentice A., Cerami C. Oral iron acutely elevates bacterial growth in human serum. Sci. Rep., 2015, no. 5, 16670. doi: 10.1038/srep16670. doi: 10.1038/srep16670.</mixed-citation><mixed-citation xml:lang="en">Cross J., Bradbury R., Fulford A., Jallow A., Wegmüller R., Prentice A., Cerami C. Oral iron acutely elevates bacterial growth in human serum. Sci. Rep., 2015, no. 5, 16670. doi: 10.1038/srep16670. doi: 10.1038/srep16670.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Danesh A., Inglis H., Jackman R., WuS. Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro. Blood, 2013, Vol. 123, no. 5, pp. 687-696.</mixed-citation><mixed-citation xml:lang="en">Danesh A., Inglis H., Jackman R., WuS. Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro. Blood, 2013, Vol. 123, no. 5, pp. 687-696.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Delobel J., Prudent M., Rubin O., CrettazD., TissotJ-D., Lion N. Subcellular fractionation of stored red blood cells reveals a compartmentbased protein carbonylation evolution. J. Proteom., 2012, Vol. 76, Spec. no., pp. 181-193.</mixed-citation><mixed-citation xml:lang="en">Delobel J., Prudent M., Rubin O., CrettazD., TissotJ-D., Lion N. Subcellular fractionation of stored red blood cells reveals a compartmentbased protein carbonylation evolution. J. Proteom., 2012, Vol. 76, Spec. no., pp. 181-193.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Deeb A., Aquina C.T., Monson J., Blumberg N., Becerra A., Fleming F. Allogeneic leukocyte-reduced red blood cell transfusion is associated with postoperative infectious complications and cancer recurrence after colon cancer resection. Dig Surg., 2020, Vol. 37, no. 2, pp. 163-170.</mixed-citation><mixed-citation xml:lang="en">Deeb A., Aquina C.T., Monson J., Blumberg N., Becerra A., Fleming F. Allogeneic leukocyte-reduced red blood cell transfusion is associated with postoperative infectious complications and cancer recurrence after colon cancer resection. Dig Surg., 2020, Vol. 37, no. 2, pp. 163-170.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Dey-Hazra E., Hertel B., Kirsch T., Woywodt A., Lovric S., Haller H., Haubitz M., Erdbruegger U. Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing. Vasc. Health Risk Manag., 2010, Vol. 6, no. 6, pp. 1125-1133.</mixed-citation><mixed-citation xml:lang="en">Dey-Hazra E., Hertel B., Kirsch T., Woywodt A., Lovric S., Haller H., Haubitz M., Erdbruegger U. Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing. Vasc. Health Risk Manag., 2010, Vol. 6, no. 6, pp. 1125-1133.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Dzik S., Murphy M. Emerging research in transfusion medicine: what to expect in 2020. Transfus. Med. Rev., 2020, Vol. 34, no. 1, pp. 1-4.</mixed-citation><mixed-citation xml:lang="en">Dzik S., Murphy M. Emerging research in transfusion medicine: what to expect in 2020. Transfus. Med. Rev., 2020, Vol. 34, no. 1, pp. 1-4.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez-Messina L., Gutierrez-Vazquez C., Rivas-Garcia E., Sánchez-Madri dF., de la Fuente H. Immunomodulatory role of microRNAs transferred by extracellular vesicles. Biol. Cell, 2015, Vol. 107, no. 3, pp. 61-77.</mixed-citation><mixed-citation xml:lang="en">Fernandez-Messina L., Gutierrez-Vazquez C., Rivas-Garcia E., Sánchez-Madri dF., de la Fuente H. Immunomodulatory role of microRNAs transferred by extracellular vesicles. Biol. Cell, 2015, Vol. 107, no. 3, pp. 61-77.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Fox L., Cox D., Lockridge J., Wang X., Chen X., Scharf L., Trott D., Ndonye R., Veerapen N., Besra G., Howell A., Cook M., Adams E., Hildebrand W., Gumperz J. Recognition of lysophospholipids by human natural killer T lymphocytes. PLoS Biol., 2009, Vol. 7, no. 10, e1000228. doi: 10.1371/journal.pbio.1000228.</mixed-citation><mixed-citation xml:lang="en">Fox L., Cox D., Lockridge J., Wang X., Chen X., Scharf L., Trott D., Ndonye R., Veerapen N., Besra G., Howell A., Cook M., Adams E., Hildebrand W., Gumperz J. Recognition of lysophospholipids by human natural killer T lymphocytes. PLoS Biol., 2009, Vol. 7, no. 10, e1000228. doi: 10.1371/journal.pbio.1000228.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ghio M., Contini P., Ubezio G., Ansaldi F., Setti M., Tripodi G. Blood transfusions with high levels of contaminating soluble HLA-I correlate with levels of soluble CD8 in recipients’ plasma; a new control factor in soluble HLA-I-mediated transfusion-modulated immunomodulation? Blood Transfus., 2014, Vol. 12, no. 1, pp. 105-108.</mixed-citation><mixed-citation xml:lang="en">Ghio M., Contini P., Ubezio G., Ansaldi F., Setti M., Tripodi G. Blood transfusions with high levels of contaminating soluble HLA-I correlate with levels of soluble CD8 in recipients’ plasma; a new control factor in soluble HLA-I-mediated transfusion-modulated immunomodulation? Blood Transfus., 2014, Vol. 12, no. 1, pp. 105-108.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ghio M., Contini P., Negrini S., Mazzei C., Zocchi M.R., Poggi A. Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-b (1), soluble Fas ligand, and soluble Class I human leukocyte antigen. Transfusion, 2011, Vol. 51, no. 7, pp. 1567-1573.</mixed-citation><mixed-citation xml:lang="en">Ghio M., Contini P., Negrini S., Mazzei C., Zocchi M.R., Poggi A. Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-b (1), soluble Fas ligand, and soluble Class I human leukocyte antigen. Transfusion, 2011, Vol. 51, no. 7, pp. 1567-1573.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Halpin A., Nahirniak S.,Campbell P., Urschel S., Kim D., West L., Pidorochynski T., Buchholz H., Conway J. HLA alloimmunization following ventricular assist device support across the age spectrum. Transplantation, 2019, Vol. 103, no. 12, pp. 2715-2724.</mixed-citation><mixed-citation xml:lang="en">Halpin A., Nahirniak S.,Campbell P., Urschel S., Kim D., West L., Pidorochynski T., Buchholz H., Conway J. HLA alloimmunization following ventricular assist device support across the age spectrum. Transplantation, 2019, Vol. 103, no. 12, pp. 2715-2724.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Hassani H., Khoshdel H., Sharifzadeh S.R., Heydari M.F., Alizadeh S., Aghideh A.N. TNF-α and TGF-β level after intraoperative allogeneic red blood cell transfusion in orthopedic operation patients. Turkish J. Med. Scien., 2017, Vol. 47, no. 6, pp. 1813-1818.</mixed-citation><mixed-citation xml:lang="en">Hassani H., Khoshdel H., Sharifzadeh S.R., Heydari M.F., Alizadeh S., Aghideh A.N. TNF-α and TGF-β level after intraoperative allogeneic red blood cell transfusion in orthopedic operation patients. Turkish J. Med. Scien., 2017, Vol. 47, no. 6, pp. 1813-1818.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hirani R., Balogh Z., Lott N., Hsu J., Irving D. Leukodepleted blood components do not remove the potential for long-term transfusion-associated microchimerism in australian major trauma patients. Chimerism, 2014, Vol. 5, no. 3, pp. 86-93.</mixed-citation><mixed-citation xml:lang="en">Hirani R., Balogh Z., Lott N., Hsu J., Irving D. Leukodepleted blood components do not remove the potential for long-term transfusion-associated microchimerism in australian major trauma patients. Chimerism, 2014, Vol. 5, no. 3, pp. 86-93.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Hirani R., Dean M., Balogh Z., Lott N., Seggie J., Hsu J., Taggart S., Maitz P., Survela L., Joseph A., Gillett M., Irving D. Donor white blood cell survival and cytokine profiles following red blood cell transfusion in Australian major trauma patients. Mol. Immunol., 2018, Vol. 103, pp. 229-234.</mixed-citation><mixed-citation xml:lang="en">Hirani R., Dean M., Balogh Z., Lott N., Seggie J., Hsu J., Taggart S., Maitz P., Survela L., Joseph A., Gillett M., Irving D. Donor white blood cell survival and cytokine profiles following red blood cell transfusion in Australian major trauma patients. Mol. Immunol., 2018, Vol. 103, pp. 229-234.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Holmes C., Levis J., Ornstein D. Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis. Clin. Exp. Metastasis, 2009, Vol. 26, no. 7, pp. 653-661.</mixed-citation><mixed-citation xml:lang="en">Holmes C., Levis J., Ornstein D. Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis. Clin. Exp. Metastasis, 2009, Vol. 26, no. 7, pp. 653-661.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Hood M., Skaar E. Nutritional immunity: transition metals at the pathogen-host interface. Nat. Rev. Microbiol., 2012, Vol. 10, no. 8, pp. 525-537.</mixed-citation><mixed-citation xml:lang="en">Hood M., Skaar E. Nutritional immunity: transition metals at the pathogen-host interface. Nat. Rev. Microbiol., 2012, Vol. 10, no. 8, pp. 525-537.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Hunsicker O., Gericke S., Graw J., Krannich A., Boemke W., Meyer O., Braicu I., Spies C., Sehouli J., Pruß A., Feldheiser A. Transfusion of red blood cells does not impact progression-free and overall survival after surgery for ovarian cancer. Transfusion, 2019, Vol. 59, no. 12, pp. 3589-3600.</mixed-citation><mixed-citation xml:lang="en">Hunsicker O., Gericke S., Graw J., Krannich A., Boemke W., Meyer O., Braicu I., Spies C., Sehouli J., Pruß A., Feldheiser A. Transfusion of red blood cells does not impact progression-free and overall survival after surgery for ovarian cancer. Transfusion, 2019, Vol. 59, no. 12, pp. 3589-3600.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobi K., Wanke C., Jacobi A., Weisbach V., Hemmerling T. Determination of eicosanoid and cytokine production in salvaged blood, stored red blood cell concentrates, and whole blood. J. Clin. Anesth., 2000, Vol. 12, no. 9, pp. 94-99.</mixed-citation><mixed-citation xml:lang="en">Jacobi K., Wanke C., Jacobi A., Weisbach V., Hemmerling T. Determination of eicosanoid and cytokine production in salvaged blood, stored red blood cell concentrates, and whole blood. J. Clin. Anesth., 2000, Vol. 12, no. 9, pp. 94-99.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Jiao C., Zheng L. Blood transfusion-related immunomodulation in patients with major obstetric haemorrhage. Vox Sanguinis, 2019, Vol. 114, no. 8, pp. 861-868.</mixed-citation><mixed-citation xml:lang="en">Jiao C., Zheng L. Blood transfusion-related immunomodulation in patients with major obstetric haemorrhage. Vox Sanguinis, 2019, Vol. 114, no. 8, pp. 861-868.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Jin Y., Damaj B., Maghazachi A. Human resting CD162, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alphaactivated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. Eur. J. Immunol., 2005, Vol. 35, no. 9, pp. 2699-2708.</mixed-citation><mixed-citation xml:lang="en">Jin Y., Damaj B., Maghazachi A. Human resting CD162, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alphaactivated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. Eur. J. Immunol., 2005, Vol. 35, no. 9, pp. 2699-2708.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kanter J., Khan S., Kelher M., Gore L., Silliman C. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates. Clin. Cancer Res., 2008, Vol. 14, no. 12, pp. 3942-3947.</mixed-citation><mixed-citation xml:lang="en">Kanter J., Khan S., Kelher M., Gore L., Silliman C. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates. Clin. Cancer Res., 2008, Vol. 14, no. 12, pp. 3942-3947.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Karam O., Tucci M., Toledano B., Robitaille N., Cousineau J., Thibault L., Lacroix J., Le Deist F. Length of storage and in vitro immunomodulation induced by prestorage leukoreduced red blood cells. Transfusion, 2009, Vol. 49, no. 11, pp. 2326-2334.</mixed-citation><mixed-citation xml:lang="en">Karam O., Tucci M., Toledano B., Robitaille N., Cousineau J., Thibault L., Lacroix J., Le Deist F. Length of storage and in vitro immunomodulation induced by prestorage leukoreduced red blood cells. Transfusion, 2009, Vol. 49, no. 11, pp. 2326-2334.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Keir A., McPhee A., Andersen C., Stark M. Plasma cytokines and markers of endothelial activation increase after packed red blood cell transfusion in the preterm infant. Pediatr. Res., 2013, Vol. 73, no. 1, pp. 75-79.</mixed-citation><mixed-citation xml:lang="en">Keir A., McPhee A., Andersen C., Stark M. Plasma cytokines and markers of endothelial activation increase after packed red blood cell transfusion in the preterm infant. Pediatr. Res., 2013, Vol. 73, no. 1, pp. 75-79.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Ki K.K., Johnson L., Faddy H.M., Flower R. L. Marks D.C., Dean M.M. Immunomodulatory effect of cryopreserved platelets: altered BDCA31 dendritic cell maturation and activation in vitro. Transfusion, 2017, Vol. 57, no. 12, pp. 2878-2887.</mixed-citation><mixed-citation xml:lang="en">Ki K.K., Johnson L., Faddy H.M., Flower R. L. Marks D.C., Dean M.M. Immunomodulatory effect of cryopreserved platelets: altered BDCA31 dendritic cell maturation and activation in vitro. Transfusion, 2017, Vol. 57, no. 12, pp. 2878-2887.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Lamiaa M., Hala Y., Hala A., Hawary R., Selim A., Aly S., Nada M., Aly H. Effect of packed red blood cell transfusion on IL-8 and sICAM-1 in premature neonates at different postnatal ages. Pediatr. Neonatol., 2019, Vol. 60, no. 5, pp. 537-542.</mixed-citation><mixed-citation xml:lang="en">Lamiaa M., Hala Y., Hala A., Hawary R., Selim A., Aly S., Nada M., Aly H. Effect of packed red blood cell transfusion on IL-8 and sICAM-1 in premature neonates at different postnatal ages. Pediatr. Neonatol., 2019, Vol. 60, no. 5, pp. 537-542.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lange M.M., van Hilten J.A., van de Watering L.M., Bijnen B.A., Roumen R.M., Putter H., Brand A., van de Velde C.J. Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. Br. J .Surg., 2009, Vol. 96, no. 7, pp. 734-740.</mixed-citation><mixed-citation xml:lang="en">Lange M.M., van Hilten J.A., van de Watering L.M., Bijnen B.A., Roumen R.M., Putter H., Brand A., van de Velde C.J. Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. Br. J .Surg., 2009, Vol. 96, no. 7, pp. 734-740.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Lapierre V., Aupérin A., Robinet E., Ferrand C., Oubouzar N., Tramalloni D., Saas P., Debaene B., Lasser P., Tiberghien P. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion, 2007, Vol. 47, no. 9, pp. 1691-1699.</mixed-citation><mixed-citation xml:lang="en">Lapierre V., Aupérin A., Robinet E., Ferrand C., Oubouzar N., Tramalloni D., Saas P., Debaene B., Lasser P., Tiberghien P. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion, 2007, Vol. 47, no. 9, pp. 1691-1699.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Luo L., Wang D., Chen M., Li M. Effects of reinfusion of the remaining blood filtered by leukocyte depletion filter on postoperative cellar immune function after cardiopulmonary bypass. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2019, Vol. 31, no. 8, pp. 989-993.</mixed-citation><mixed-citation xml:lang="en">Luo L., Wang D., Chen M., Li M. Effects of reinfusion of the remaining blood filtered by leukocyte depletion filter on postoperative cellar immune function after cardiopulmonary bypass. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2019, Vol. 31, no. 8, pp. 989-993.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Mathivanan S., Ji H., Simpson R. Exosomes: extracellular organelles important in intercellular communication. J. Proteom., 2010, Vol. 73, no. 10, pp. 1907-1920.</mixed-citation><mixed-citation xml:lang="en">Mathivanan S., Ji H., Simpson R. Exosomes: extracellular organelles important in intercellular communication. J. Proteom., 2010, Vol. 73, no. 10, pp. 1907-1920.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Matsubayashi H., Weidner J., Miraglia C., McIntyre J. Platelet membrane early activation markers during prolonged storage. Thromb. Res., 1999, Vol. 93, no. 4, pp. 151-160.</mixed-citation><mixed-citation xml:lang="en">Matsubayashi H., Weidner J., Miraglia C., McIntyre J. Platelet membrane early activation markers during prolonged storage. Thromb. Res., 1999, Vol. 93, no. 4, pp. 151-160.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Mittal S., Cho K., Ishido S., Roche P.A. Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I induction regulates antigen presentation by macrophages but not dendritic cells. J. Biol. Chem., 2015, Vol. 290, no. 45, pp. 27158-27167.</mixed-citation><mixed-citation xml:lang="en">Mittal S., Cho K., Ishido S., Roche P.A. Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I induction regulates antigen presentation by macrophages but not dendritic cells. J. Biol. Chem., 2015, Vol. 290, no. 45, pp. 27158-27167.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Mulligan J., Rosenzweig S., Young M. Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2. J. Immunother., 2010, Vol. 33, no. 2, pp. 126-135.</mixed-citation><mixed-citation xml:lang="en">Mulligan J., Rosenzweig S., Young M. Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2. J. Immunother., 2010, Vol. 33, no. 2, pp. 126-135.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Muszynski J., Bale J., Nateri J., Nicol K. Supernatants from stored red blood cell (RBC) units, but not RBCderived microvesicles, suppress monocyte function in vitro. Transfusion, 2015, Vol. 55, no. 8, pp. 1937-1945.</mixed-citation><mixed-citation xml:lang="en">Muszynski J., Bale J., Nateri J., Nicol K. Supernatants from stored red blood cell (RBC) units, but not RBCderived microvesicles, suppress monocyte function in vitro. Transfusion, 2015, Vol. 55, no. 8, pp. 1937-1945.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Muszynski J., Spinella P., Cholette J. Acker J., Hall M., Juffermans N., Kelly D., Blumberg N., Nicol K., Liedel J., Doctor A., Remy K., Tucci M., Lacroix J., Norris P. Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness. Transfusion, 2017, Vol. 57, no. 1, pp. 195-206.</mixed-citation><mixed-citation xml:lang="en">Muszynski J., Spinella P., Cholette J. Acker J., Hall M., Juffermans N., Kelly D., Blumberg N., Nicol K., Liedel J., Doctor A., Remy K., Tucci M., Lacroix J., Norris P. Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness. Transfusion, 2017, Vol. 57, no. 1, pp. 195-206.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Nagura Y., Tsuno N., Tanaka M., Matsuhashi M., Takahashi K. The effect of prestorage whole-blood leukocyte reduction on cytokines/chemokines levels in autologous CPDA-1 whole blood. Transfus. Apher. Sci., 2013, Vol. 49, no. 2, pp. 223-230.</mixed-citation><mixed-citation xml:lang="en">Nagura Y., Tsuno N., Tanaka M., Matsuhashi M., Takahashi K. The effect of prestorage whole-blood leukocyte reduction on cytokines/chemokines levels in autologous CPDA-1 whole blood. Transfus. Apher. Sci., 2013, Vol. 49, no. 2, pp. 223-230.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson K.A., Aldea G.S., Warner P., Latchman Y., Gunasekera D., Tamir A., Gernsheimer T., Bolgiano D., Slichter S.J. Transfusion-related immunomodulation: gamma irradiation alters the effects of leukoreduction on alloimmunization. Transfusion, 2019, Vol. 59, no. 11, pp. 3396-3404.</mixed-citation><mixed-citation xml:lang="en">Nelson K.A., Aldea G.S., Warner P., Latchman Y., Gunasekera D., Tamir A., Gernsheimer T., Bolgiano D., Slichter S.J. Transfusion-related immunomodulation: gamma irradiation alters the effects of leukoreduction on alloimmunization. Transfusion, 2019, Vol. 59, no. 11, pp. 3396-3404.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Olofsson K.E., Andersson L., Nilsson J., Bjorkbacka H. Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem. Biophys. Res. Commun., 2008, Vol. 370, no. 2, pp. 348-352.</mixed-citation><mixed-citation xml:lang="en">Olofsson K.E., Andersson L., Nilsson J., Bjorkbacka H. Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem. Biophys. Res. Commun., 2008, Vol. 370, no. 2, pp. 348-352.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Ozment C.P., Mamo L.B., Campbell M.L., Lokhnygina Y., Ghio A., Turi J. Transfusion-related biologic effects and free hemoglobin, heme, and iron. Transfusion, 2013, Vol. 53, no. 4, pp. 732-740.</mixed-citation><mixed-citation xml:lang="en">Ozment C.P., Mamo L.B., Campbell M.L., Lokhnygina Y., Ghio A., Turi J. Transfusion-related biologic effects and free hemoglobin, heme, and iron. Transfusion, 2013, Vol. 53, no. 4, pp. 732-740.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Patel M.B., Proctor K.G., Majetschak M. Extracellular ubiquitin increases in packed red blood cell units during storage. J. Surg. Res., 2006, Vol. 135, no. 2. pp. 226-232.</mixed-citation><mixed-citation xml:lang="en">Patel M.B., Proctor K.G., Majetschak M. Extracellular ubiquitin increases in packed red blood cell units during storage. J. Surg. Res., 2006, Vol. 135, no. 2. pp. 226-232.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Petri B., Phillipson M., Kubes P. The physiology of leukocyte recruitment: an in vivo perspective. J. Immunol., 2008, Vol. 180, no. 10, pp. 6439-6436.</mixed-citation><mixed-citation xml:lang="en">Petri B., Phillipson M., Kubes P. The physiology of leukocyte recruitment: an in vivo perspective. J. Immunol., 2008, Vol. 180, no. 10, pp. 6439-6436.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Remy K., Natanson C., Klein H.G. The influence of the storage lesion(s) on pediatric red cell transfusion. Curr. Opin. Pediatr., 2015, Vol. 27, no. 3, pp. 277-285.</mixed-citation><mixed-citation xml:lang="en">Remy K., Natanson C., Klein H.G. The influence of the storage lesion(s) on pediatric red cell transfusion. Curr. Opin. Pediatr., 2015, Vol. 27, no. 3, pp. 277-285.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Ren Y., Lin C., Li Z., Chen X.Y. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis. Histopathology, 2005, Vol. 46, no. 6, pp. 659-667.</mixed-citation><mixed-citation xml:lang="en">Ren Y., Lin C., Li Z., Chen X.Y. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis. Histopathology, 2005, Vol. 46, no. 6, pp. 659-667.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Robinson D. The role of regulatory T lymphocytes in asthma pathogenesis. Curr. Allergy Asthma Rep., 2005, Vol. 5, no. 2, pp. 136-141.</mixed-citation><mixed-citation xml:lang="en">Robinson D. The role of regulatory T lymphocytes in asthma pathogenesis. Curr. Allergy Asthma Rep., 2005, Vol. 5, no. 2, pp. 136-141.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Saas P., Angelot F., Bardiaux L., Seillès E., Garnache-Ottou F., Perruche S. Phosphatidylserine-expressing cell by-products in transfusion: a pro-inflammatory or an anti-inflammatory effect? Transfus. Clin. Biol., 2012, Vol. 19, no. 3, pp. 90-97.</mixed-citation><mixed-citation xml:lang="en">Saas P., Angelot F., Bardiaux L., Seillès E., Garnache-Ottou F., Perruche S. Phosphatidylserine-expressing cell by-products in transfusion: a pro-inflammatory or an anti-inflammatory effect? Transfus. Clin. Biol., 2012, Vol. 19, no. 3, pp. 90-97.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Sadallah S., Eken C., Martin P., Schifferli J. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J. Immunol., 2011, Vol. 186, no. 11, pp. 6543-6552</mixed-citation><mixed-citation xml:lang="en">Sadallah S., Eken C., Martin P., Schifferli J. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J. Immunol., 2011, Vol. 186, no. 11, pp. 6543-6552</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Saris A., Kerkhoffs J.L., Norris P.J., van Ham M., Brinke A., Brand A., van der Meer P. F., Zwaginga J.J. The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients. Transfusion, 2019, Vol. 59, no. 2, pp. 470-481.</mixed-citation><mixed-citation xml:lang="en">Saris A., Kerkhoffs J.L., Norris P.J., van Ham M., Brinke A., Brand A., van der Meer P. F., Zwaginga J.J. The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients. Transfusion, 2019, Vol. 59, no. 2, pp. 470-481.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Silliman C., Clay K., Thurman G., Johnson C., Ambruso D. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J. Lab. Clin. Med., 1994, Vol. 124, no. 5, pp. 684-694.</mixed-citation><mixed-citation xml:lang="en">Silliman C., Clay K., Thurman G., Johnson C., Ambruso D. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J. Lab. Clin. Med., 1994, Vol. 124, no. 5, pp. 684-694.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Seghatchian J. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers. Transfus. Apher. Sci., 2006, Vol. 34, no. 1, pp. 125-130.</mixed-citation><mixed-citation xml:lang="en">Seghatchian J. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers. Transfus. Apher. Sci., 2006, Vol. 34, no. 1, pp. 125-130.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Soontrapa K., Honda T., Sakata D., Yao C., Hirata T., Hori S., Matsuoka T., Kita Y., Shimizu T., Kabashima K., Narumiya S. Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression. Proc. Natl. Acad. Sci. USA, 2011, Vol. 108, no. 16, pp. 6668-6673.</mixed-citation><mixed-citation xml:lang="en">Soontrapa K., Honda T., Sakata D., Yao C., Hirata T., Hori S., Matsuoka T., Kita Y., Shimizu T., Kabashima K., Narumiya S. Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression. Proc. Natl. Acad. Sci. USA, 2011, Vol. 108, no. 16, pp. 6668-6673.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Suksompong S., Tassaneetrithep B., Ariyawatkul T., Sirivanasandha B. Allogeneic red cell transfusion and its influence on relevant humoral and cellular immunological parameters: A prospective observational trial. Eur. J. Anaesthesiol,, 2019, Vol. 36, no. 11, pp. 814-824.</mixed-citation><mixed-citation xml:lang="en">Suksompong S., Tassaneetrithep B., Ariyawatkul T., Sirivanasandha B. Allogeneic red cell transfusion and its influence on relevant humoral and cellular immunological parameters: A prospective observational trial. Eur. J. Anaesthesiol,, 2019, Vol. 36, no. 11, pp. 814-824.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Tetta C., Ghigo E., Silengo L., Deregibus M.C., Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine, 2013, Vol. 44, no. 1, pp. 11-19.</mixed-citation><mixed-citation xml:lang="en">Tetta C., Ghigo E., Silengo L., Deregibus M.C., Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine, 2013, Vol. 44, no. 1, pp. 11-19.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Vlaar A., Hofstra J., Kulik W., van Lenthe H., Nieuwland R., Schultz M., Levi M., Roelofs J., Tool A., de Korte D., Juffermans N. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood, 2010, Vol. 116, no. 8, pp. 1360-1368.</mixed-citation><mixed-citation xml:lang="en">Vlaar A., Hofstra J., Kulik W., van Lenthe H., Nieuwland R., Schultz M., Levi M., Roelofs J., Tool A., de Korte D., Juffermans N. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood, 2010, Vol. 116, no. 8, pp. 1360-1368.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Vallion R., Bonnefoy F., Daoui A.Vieille L., Tiberghien P., Saas P., Perruche S. Transforming growth factor-b released by apoptotic white blood cells during red blood cell storage promotes transfusion-induced alloimmunomodulation. Transfusion, 2015, Vol. 55, no. 7, pp. 1721-1735.</mixed-citation><mixed-citation xml:lang="en">Vallion R., Bonnefoy F., Daoui A.Vieille L., Tiberghien P., Saas P., Perruche S. Transforming growth factor-b released by apoptotic white blood cells during red blood cell storage promotes transfusion-induced alloimmunomodulation. Transfusion, 2015, Vol. 55, no. 7, pp. 1721-1735.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">van Hilten J., van de Watering L., van Bockel J., van de Velde C., Kievit J., Brand R., van Den Hout W., Geelkerken R., Roumen R., Wesselink R., Koopman-van Gemert A., Koning J., Brand A. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ, 2004, Vol. 328, no. 451, 1281. doi: 10.1136/bmj.38103.735266.55.</mixed-citation><mixed-citation xml:lang="en">van Hilten J., van de Watering L., van Bockel J., van de Velde C., Kievit J., Brand R., van Den Hout W., Geelkerken R., Roumen R., Wesselink R., Koopman-van Gemert A., Koning J., Brand A. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ, 2004, Vol. 328, no. 451, 1281. doi: 10.1136/bmj.38103.735266.55.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Walker E., Walker S. Effects of iron overload on the immune system. Ann. Clin. Lab. Sci., 2000, Vol. 30, no. 4, pp.354-365.</mixed-citation><mixed-citation xml:lang="en">Walker E., Walker S. Effects of iron overload on the immune system. Ann. Clin. Lab. Sci., 2000, Vol. 30, no. 4, pp.354-365.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Wang D., Cortes-Puch I., Sun J., Solomon S., Kanias T., Remy K., Feng J., Alimchandani M., Quezado M., Helms C., Perlegas A., Gladwin M., Kim-Shapiro D., Klein H., Natanson H. Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia. Transfusion, 2014, Vol. 54, no. 7, pp. 1712-1724.</mixed-citation><mixed-citation xml:lang="en">Wang D., Cortes-Puch I., Sun J., Solomon S., Kanias T., Remy K., Feng J., Alimchandani M., Quezado M., Helms C., Perlegas A., Gladwin M., Kim-Shapiro D., Klein H., Natanson H. Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia. Transfusion, 2014, Vol. 54, no. 7, pp. 1712-1724.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Xiong Z., Cavaretta J., Qu L., Stolz D.B., Triulzi D., Lee J. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion, 2011, Vol. 51, no. 3, pp. 610-621.</mixed-citation><mixed-citation xml:lang="en">Xiong Z., Cavaretta J., Qu L., Stolz D.B., Triulzi D., Lee J. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion, 2011, Vol. 51, no. 3, pp. 610-621.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamoto S., Niida S., Azuma E.,Yanagibashi T., Muramatsu M., Huang T.T., Sagara H., Higaki S., Ikutani M., Nagai Y., Takatsu K., Miyazaki K., Hamashima T., Mori H., Matsuda N., Ishii Y., Sasahara M. Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes. Sci Rep., 2015, Vol. 5, 8505. doi: 10.1038/srep08505.</mixed-citation><mixed-citation xml:lang="en">Yamamoto S., Niida S., Azuma E.,Yanagibashi T., Muramatsu M., Huang T.T., Sagara H., Higaki S., Ikutani M., Nagai Y., Takatsu K., Miyazaki K., Hamashima T., Mori H., Matsuda N., Ishii Y., Sasahara M. Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes. Sci Rep., 2015, Vol. 5, 8505. doi: 10.1038/srep08505.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang B., Yin Y., Lai R., Lim S. Immunotherapeutic potential of extracellular vesicles. Front. Immunol., 2014, Vol. 5, 518. doi: 10.3389/fimmu.2014.00518.</mixed-citation><mixed-citation xml:lang="en">Zhang B., Yin Y., Lai R., Lim S. Immunotherapeutic potential of extracellular vesicles. Front. Immunol., 2014, Vol. 5, 518. doi: 10.3389/fimmu.2014.00518.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu X., Yu B., You P., Wua Y., Fanga Y., Yanga L., Xiaa R. Ubiquitin released in the plasma of whole blood during storage promotes mRNA expression of Th2 cytokines and Th2-inducing transcription factors. Transfus.</mixed-citation><mixed-citation xml:lang="en">Zhu X., Yu B., You P., Wua Y., Fanga Y., Yanga L., Xiaa R. Ubiquitin released in the plasma of whole blood during storage promotes mRNA expression of Th2 cytokines and Th2-inducing transcription factors. Transfus.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
